The Biden administration announced Monday that it would purchase 3.2 million doses of the Novavax COVID-19 vaccine. It will be offered at no cost to states and federal partners. “We remain committed ...

NEW YORK (WABC) -- The biotechnology company Novavax plans to submit complete data to the US Food and Drug Administration soon for possible emergency use authorization of its coronavirus vaccine, CEO ...

A COVID-19 vaccine that could soon win federal approval may offer a boost for the U.S. military: an opportunity to get shots into some of the thousands of service members who have refused the other ...

This is a major update to a story that was first published earlier in September. It reflects what readers need to know after an important vaccine advisory panel met on Thursday and Friday. Getting a ...

HOUSTON, Texas (KTRK) -- Pfizer and Moderna doses are making their way to cities across the country, but it's simply not enough to meet the need. "Right now, there's a huge demand for a limited supply ...

Have you seen ads for the new low-dose COVID vaccine called mNEXSpike and wondered what it's all about? Us too! So we did ...

Vinay Prasad, a top FDA official, blamed Covid shots for playing a role in the deaths of 10 children in the memo he sent to ...

So back to the premise that Novavax could be a better vaccine stock than Merck. The probability that a late-stage vaccine could win approval is around 74%, according to data from the biopharmaceutical ...

A spokesman for Moderna, which makes Covid vaccines, pointed to a September statement saying the company didn’t know of any ...